Αποτελέσματα Αναζήτησης
23 Ιαν 2024 · INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer and infectious diseases, today announced that a 1-for-12 reverse stock split of its outstanding shares of common stock will be effective as of 5:00 p.m. Eastern Time on Wednesday ...
23 Ιαν 2024 · At the effective time of the reverse split, every 12 issued and outstanding shares of the company's common stock will automatically be combined into one issued and outstanding share of the...
23 Ιαν 2024 · Stockholders who would otherwise be entitled to receive a fractional share will be entitled to receive a cash payment. The reverse stock split will affect all stockholders uniformly and will not...
6 Μαρ 2024 · Shareholders of the Company authorized the Board of Directors to approve the reverse stock split at a special meeting of stockholders held on January 12, 2024. Outstanding share amounts have been restated to reflect the reverse stock split on a retroactive basis for all periods presented.
23 Ιαν 2024 · Inovio Pharmaceuticals, Inc. (INO) will effect a one-for-twelve (1-12) reverse split of its Common Stock. The reverse stock split will become effective on Thursday, January 25, 2024. In conjunction with the reverse split, the CUSIP number will change to 45773H409.
INOVIO, a biotechnology entity at the forefront of DNA medicine innovation, has declared a pivotal corporate maneuver with the initiation of a 1-for-12 reverse stock split of its common stock. This adjustment is scheduled to be effective at the close of business on January 24, 2024.
23 Ιαν 2024 · Inovio Pharmaceuticals, Inc. (INO) has announced a 1-for-12 reverse stock split. As a result of the reverse stock split, each INO Common Share will be converted into the right to receive approximately 0.083333
